Does LEVODOPA Cause Therapeutic product effect delayed? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Therapeutic product effect delayed have been filed in association with LEVODOPA (L-Dopa). This represents 0.9% of all adverse event reports for LEVODOPA.
59
Reports of Therapeutic product effect delayed with LEVODOPA
0.9%
of all LEVODOPA reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From LEVODOPA?
Of the 59 reports, 2 (3.4%) required hospitalization.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVODOPA. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does LEVODOPA Cause?
Cough (2,142)
Drug ineffective (1,036)
Parkinson's disease (761)
Device issue (565)
Product residue present (534)
Device difficult to use (466)
Condition aggravated (463)
Device use issue (443)
Dyskinesia (411)
Death (335)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
SECUKINUMAB (162)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
DUPILUMAB (90)
IBUPROFEN (88)
DICLOFENAC (85)
Which LEVODOPA Alternatives Have Lower Therapeutic product effect delayed Risk?
LEVODOPA vs LEVOFLOXACIN
LEVODOPA vs LEVOKETOCONAZOLE
LEVODOPA vs LEVOLEUCOVORIN
LEVODOPA vs LEVOMEPROMAZINE
LEVODOPA vs LEVOMETHADONE